Cargando…

A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus

BACKGROUND: To evaluate the safety of pegaptanib sodium 0.3 mg intravitreal injection in the treatment of neovascular age-related macular degeneration in subjects with or without diabetes mellitus. METHODS: A pooled, retrospective, analysis was conducted of data from 9 sponsor-administered, randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dombi, Theresa, Kwok, Kenneth K, Sultan, Marla B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472216/ https://www.ncbi.nlm.nih.gov/pubmed/22871086 http://dx.doi.org/10.1186/1471-2415-12-37

Ejemplares similares

Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008)

Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema
por: Querques, G., et al.
Publicado: (2009)

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008)

Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006)

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study
por: Friberg, Thomas R, et al.
Publicado: (2010)

Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
por: Feucht, Nikolaus, et al.
Publicado: (2008)

Population pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema
por: Basile, Anthony S, et al.
Publicado: (2015)

Clinical experience with pegaptanib sodium
por: Rosina, Chiara, et al.
Publicado: (2008)

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
por: Singerman, L J, et al.
Publicado: (2008)

Pegaptanib sodium for ocular vascular disease
por: Shukla, Dhananjay, et al.
Publicado: (2007)

Effect of Switching Therapy to Pegaptanib in Eyes With the Persistent Cases of Exudative Age-Related Macular Degeneration
por: Shiragami, Chieko, et al.
Publicado: (2014)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
por: Kiire, Christine A, et al.
Publicado: (2015)

Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size
por: Nishimura, Yoshihiro, et al.
Publicado: (2012)

An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
por: Sivaprasad, Sobha, et al.
Publicado: (2014)

Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study
por: Weber, Pamela A, et al.
Publicado: (2010)

The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy
por: Zhang, Rui, et al.
Publicado: (2017)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin)
por: Nagpal, Manish, et al.
Publicado: (2007)

Potent anti‐angiogenesis and anti‐tumour activity of pegaptanib‐loaded tetrahedral DNA nanostructure
por: Xie, Xueping, et al.
Publicado: (2019)

Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization
por: Lytvynchuk, Lyubomyr, et al.
Publicado: (2015)

Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials
por: Leiter, L. A., et al.
Publicado: (2018)

Relationship between macular pigment and visual function in subjects with early age-related macular degeneration
por: Akuffo, Kwadwo Owusu, et al.
Publicado: (2017)

Protective Effect of Hydrogen on Sodium Iodate-Induced Age-Related Macular Degeneration in Mice
por: Liu, Yanli, et al.
Publicado: (2018)

Foveal slope measurements in subjects with high-risk of age-related macular degeneration
por: Raman, Rajiv, et al.
Publicado: (2013)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration
por: Yasuma, Tetsuhiro R., et al.
Publicado: (2010)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Brolucizumab for macular degeneration
Publicado: (2020)

Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen
por: Kamao, Hiroyuki, et al.
Publicado: (2021)

Effectiveness of Current Treatments for Wet Age-Related Macular Degeneration in Japan: A Systematic Review and Pooled Data Analysis
por: Takahashi, Kanji, et al.
Publicado: (2022)

Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
por: Riazi-Esfahani, Hamid, et al.
Publicado: (2023)

Macular and Plasma Xanthophylls Are Higher in Age-related Macular Degeneration than in Normal Aging: Alabama Study on Early Age-related Macular Degeneration 2 Baseline
por: McGwin, Gerald, et al.
Publicado: (2022)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Advances in the management of macular degeneration
por: Singer, Michael
Publicado: (2014)

Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration
por: Chen, Youxin, et al.
Publicado: (2012)

Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
por: Péntek, Márta, et al.
Publicado: (2017)

Diabetes Mellitus and Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
por: Chen, Xue, et al.
Publicado: (2014)

Autofluorescent Organelles Within the Retinal Pigment Epithelium in Human Donor Eyes With and Without Age-Related Macular Degeneration
por: Bermond, Katharina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8u44mik070mpufarpsfdulb4kn